CELL THERAPY CENTER IN CHINA

The allogeneic immune cell preparation PB103 will achieve "global brand, all-round service" as the goal, with Shenzhen Dapeng as the cell production base, establish cell therapy centers in various provincial cities, and successfully expand the inland immune cell therapy market hinterland..

Cell Therapy Center

HANGZHOU PROTISTA BIOTECHNOLOGY CELL DEVELOPMENT AND PRODUCTION CENTER

Precision Biotechnology International wholly owns Hangzhou Native Biotechnology Co., Ltd., which was established in February 2018 with a factory building of 1,600 square meters meeting GMP standard, and located in XiaoShan Economic & Technological Development Zone, Hangzhou. It was designed according to GMP standards, and the production area of cell preparation center adopts Class A aseptic isolation system. It is the first enterprise in China to adopt aseptic fully isolated closed system, which lays a foundation for the automation and artificial intelligence of cell proliferation and culture, realizing the whole dynamic 100-level operation process of cell therapy products. Native Biotechnology ’s GMP laboratory and cell preparation center can fully meet the production demand of allogeneic natural killer immune cell preparations PB103 in clinical trials.

CELL PRODUCTION BASE AND CELL THERAPY CENTER

Precision Biotech has established R&D and cell production bases, cell freezing centers, cell therapy centers, radio therapy centers, thermotherapy centers, anti-aging treatment centers, and special intelligent cancer specialized hospitals in Dapeng New District, Shenzhen, and at the same time carried out phase I/II clinical trials of allogeneic natural killer immune cell PB103 preparations in China and also carrying out Breakthrough Therapy Drug Program in China therefore the product can be marketed in advance; it is expected that Breakthrough Therapy Drug Program can be done by the end of 2025 and rapidly enter the China market and saving more lives and patients with stage IV non-small cell lung cancer.

Precision Biotech owns cell storage preparation centers and production bases in Taiwan, Shenzhen and Hangzhou, that meet GMP and FDA international top standards,completed biological laboratories and quality and safety assurance systems. Established a production quality management system in line with GMP standards, the laboratory is equipped with sterile full isolation closed system, isolator, incubator, centrifuge, flow cytometer, microbial identification instrument and other production and quality inspection equipment, Aseptic operation in Class A environment to effectively prevent product contamination; At the same time, the company adopts mycoplasma examination method, rapid sterility examination method and other cell product quality control methods to solve the key technical problems of large-scale production and quality inspection of immune cell drugs, and realize the standardization and industrial production of immune cell drugs.